Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.2K
Overview
44.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Lung-Targeted γδ T Cell Nanovaccine Couples Pulmonary Immune Priming to Systemic Antitumor Immunity in Non-Small-Cell Lung Cancer.

ACS nano·2026
Same author

Integrating transcriptomics and metabolomics reveals the molecular landscape of sperm maturation driven by regional differentiation in the epididymis of Guizhou-Guiqian semi-fine wool sheep.

Genomics·2026
Same author

Clinical and Genetic Characteristics of Children with Pelizaeus-Merzbacher Disease.

Journal of child neurology·2026
Same author

Identification of cardiovascular disease in patients with kidney stone disease using explainable machine learning.

Frontiers in cardiovascular medicine·2026
Same author

Analyzing the Influence of Surgical Sequence on Perioperative Circulating Tumor Cells in Patients with Resectable Non-Small Cell Lung Cancer.

Cancer management and research·2026
Same author

Functional Polyesters: Tailoring Structure and Biomedical Functions.

Polymer science & technology (Washington, D.C.)·2026

Related Experiment Video

Updated: Jun 14, 2025

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.4K

Precision Nanovaccines for Potent Vaccination.

Hong Liu1,2, Haolin Chen3, Zeyu Yang3

  • 1College of Chemistry and Molecular Science, Henan University, Zhengzhou 450046, China.

JACS Au
|August 30, 2024
PubMed
Summary

Nanoparticulate vaccines offer precise control over immune responses by optimizing size, shape, and antigen delivery. Rational design tailored to tissue microenvironments enhances vaccine efficacy and therapeutic potential.

More Related Videos

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.5K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.5K

Related Experiment Videos

Last Updated: Jun 14, 2025

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

4.4K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
00:10

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

7.5K
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
08:07

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

2.5K

Area of Science:

  • Nanotechnology in vaccinology
  • Immunology and vaccine development
  • Precision medicine and drug delivery

Background:

  • Nanoparticulate vaccines offer advantages over traditional vaccines, including enhanced antigen delivery (proteins, peptides, nucleic acids) and improved lymph node targeting.
  • They facilitate crossing biological barriers, targeting immune cells like antigen-presenting cells (APCs), and enable controlled release and cross-presentation.
  • The complex orchestration of immune responses involving various immune cells and tissue microenvironments necessitates precise vaccine design.

Purpose of the Study:

  • To summarize the role of nanoparticulate vaccines with precisely engineered properties (size, shape, charge, spatial antigen/adjuvant management) for precision vaccination.
  • To highlight the importance of rational nanoparticulate vaccine design based on anatomical and immunological microstructures of target tissues.
  • To discuss the necessity of considering target delivery and controlled release for achieving precise immune responses and therapeutic effects, including tumor microenvironment modulation.

Main Methods:

  • Review and synthesis of current research on nanoparticulate vaccine design and function.
  • Analysis of how physical and chemical properties of nanoparticles influence immune cell interactions and distribution.
  • Discussion of strategies for tailoring nanoparticulate vaccines to specific target tissues and immune microenvironments.

Main Results:

  • Precise control over nanoparticle characteristics enables targeted delivery, enhanced immune cell engagement, and modulated immune responses.
  • Rational design considering tissue-specific microenvironments significantly impacts vaccine performance and efficacy.
  • Nanovaccines demonstrate potential in remodeling suppressed tumor microenvironments and modulating immune cell activity.

Conclusions:

  • Precision engineering of nanoparticulate vaccines is crucial for regulating immune distribution, targeting, and response beyond simple pharmacokinetic improvements.
  • Tailoring nanovaccine design to anatomical and immunological contexts is essential for achieving desired therapeutic outcomes.
  • Nanoparticulate vaccines offer a promising platform for developing advanced immunotherapies, including those targeting cancer.